Sangui Biotech International, Inc.
SGBI · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $65 | $137 | $54 | $39 |
| % Growth | -52.8% | 152.2% | 40.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $65 | $137 | $54 | $39 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $38 | $42 | $35 | $38 |
| SG&A Expenses | $38 | $42 | $35 | $38 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $38 | $42 | $35 | $38 |
| Operating Income | $26 | $95 | $20 | $1 |
| % Margin | 40.7% | 69.1% | 36% | 1.9% |
| Other Income/Exp. Net | -$41 | $57 | -$37 | $1 |
| Pre-Tax Income | -$14 | $152 | -$18 | $2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$19 | $141 | -$21 | $1 |
| % Margin | -28.7% | 103.1% | -38.1% | 1.9% |
| EPS | -0 | 0.001 | -0 | 0 |
| % Growth | -114.3% | 800% | -3,433.3% | – |
| EPS Diluted | -0 | 0.001 | -0 | 0 |
| Weighted Avg Shares Out | 211,125 | 210,186 | 211,398 | 238,000 |
| Weighted Avg Shares Out Dil | 209,902 | 209,902 | 209,902 | 209,902 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $4 | $5 | $5 | $5 |
| Depreciation & Amortization | -$26 | -$95 | -$20 | $0 |
| EBITDA | $0 | $0 | $0 | $1 |
| % Margin | 0% | 0% | 0% | 2.1% |